Home|Journals|Articles by Year|Audio Abstracts

Case Report

RMJ. 2017; 42(3): 432-434

A rare case of vein of Galen thrombosis: Exploring a potential role for novel oral anticoagulants (NOACs) in cerebral deep vein thrombosis

Liyana Najwa Inche Mat, Wan Aliaa Wan Sulaiman, Hoo Fan Kee, Hakimah Sallehuddin, Hamidon Basri.


Cerebral deep vein thrombosis is rare but it carries high morbidity and mortality. The mainstay of treatment is anticoagulation with vitamin K antagonist (VKA). However, VKA has a lot of drawback of fatal bleeding in Asian population, drug-drug and drug-food interactions and the need for frequent INR monitoring when compared to novel oral anticoagulants (NOACs). Here, we present a case of a 52-year-old lady who was admitted with 3 days history of a headache and confusion. Physical examinations revealed no long tract signs and blood investigations were normal. Thrombosis of the vein of Galen was diagnosed on MRI of the brain. We describe successful treatment with subcutaneous low molecular weight heparin for 2 weeks followed by oral direct thrombin inhibitor dabigatran.

Key words: Cerebral deep vein thrombosis, Vein of Galen, direct thrombin inhibitors.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.